Skip to Content
Find More Like This
Return to Search

Development of genetically engineered bacteria for production of selected aromatic compounds

United States Patent

April 3, 2001
View the Complete Patent at the US Patent & Trademark Office
Idaho National Laboratory - Visit the Technology Transfer and Commercialization Office Website
The cloning and expression of genes in the common aromatic pathway of E. coli are described. A compound for which chorismate, the final product of the common aromatic pathway, is an anabolic intermediate can be produced by cloning and expressing selected genes of the common aromatic pathway and the genes coding for enzymes necessary to convert chorismate to the selected compound. Plasmids carrying selected genes of the common aromatic pathway are also described.
Ward; Thomas E. (Idaho Falls, ID), Watkins; Carolyn S. (Idaho Falls, ID), Bulmer; Deborah K. (Henderson, NV), Johnson; Bruce F. (Scotia, NY), Amaratunga; Mohan (Clifton Park, NY)
Bechtel BWXT Idaho, LLC (Idaho Falls, ID)
09/ 064,693
April 22, 1998
CONTRACTUAL ORIGIN OF THE INVENTION The United States has rights in this invention pursuant to Contract No. DE-AC07-94ID13223 between the U.S. Department of Energy and Lockheed Martin Idaho Technologies Company.